Medical genetics: 1. Clinical teratology in the age of genomics

Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Medical Association journal 2002-08, Vol.167 (3), p.265-273
Hauptverfasser: Polifka, Janine E, Friedman, J.M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 273
container_issue 3
container_start_page 265
container_title Canadian Medical Association journal
container_volume 167
creator Polifka, Janine E
Friedman, J.M
description Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_117475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>153561031</sourcerecordid><originalsourceid>FETCH-LOGICAL-h319t-9b36f57d8e33ece628ed19e93dabc1fa5bf8838b60ae4b95d3b8b73de3f2e2813</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMobk7_BSk--FbJV9NEEJHhF0x80eeQtLdtRtvMtrPsvzdzU_Tpwrm_c-7lHKAp4VLGlFF1iKYYYxlzjtUEnfT9EuOgY36MJoQSKUiaTNHtC-QuM3VUQguDy_rriFxF89q13-oAnRl87ctN5NpoqCAyJUS-2OK-CfgpOipM3cPZfs7Q-8P92_wpXrw-Ps_vFnHFiBpiZZkokjSXwBhkIKiEnChQLDc2I4VJbCElk1ZgA9yqJGdW2pTlwAoKVBI2Qze73NXaNpBn0A6dqfWqc43pNtobp_9vWlfp0n9qQlKeJsF_sfd3_mMN_aCXft214WUdKlFCcLqFzv8e-U3_qSsAlzugcmU1ug5035i6DjjR4zgSkWqmqUjYFyxsdUo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204966425</pqid></control><display><type>article</type><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Polifka, Janine E ; Friedman, J.M</creator><creatorcontrib>Polifka, Janine E ; Friedman, J.M</creatorcontrib><description>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</description><identifier>ISSN: 0008-4409</identifier><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>PMID: 12186175</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Canada: Can Med Assoc</publisher><subject>Adult ; Alcohol Drinking - adverse effects ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Congenital diseases ; Drugs ; Environmental Exposure ; Epilepsy - drug therapy ; Female ; Genetic Counseling ; Genetic Predisposition to Disease ; Genetic Testing ; Genetics ; Genetics, Medical - trends ; Humans ; Physiological aspects ; Pregnancy ; Review ; Risk Assessment ; Smoking - adverse effects ; Teratogens - toxicity ; Toxic chemicals ; Valproic Acid - adverse effects ; Valproic Acid - therapeutic use</subject><ispartof>Canadian Medical Association journal, 2002-08, Vol.167 (3), p.265-273</ispartof><rights>Copyright Canadian Medical Association Aug 6, 2002</rights><rights>2002 Canadian Medical Association or its licensors</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC117475/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC117475/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12186175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polifka, Janine E</creatorcontrib><creatorcontrib>Friedman, J.M</creatorcontrib><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><title>Canadian Medical Association journal</title><addtitle>CMAJ</addtitle><description>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</description><subject>Adult</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Congenital diseases</subject><subject>Drugs</subject><subject>Environmental Exposure</subject><subject>Epilepsy - drug therapy</subject><subject>Female</subject><subject>Genetic Counseling</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Testing</subject><subject>Genetics</subject><subject>Genetics, Medical - trends</subject><subject>Humans</subject><subject>Physiological aspects</subject><subject>Pregnancy</subject><subject>Review</subject><subject>Risk Assessment</subject><subject>Smoking - adverse effects</subject><subject>Teratogens - toxicity</subject><subject>Toxic chemicals</subject><subject>Valproic Acid - adverse effects</subject><subject>Valproic Acid - therapeutic use</subject><issn>0008-4409</issn><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpVkN1LwzAUxYMobk7_BSk--FbJV9NEEJHhF0x80eeQtLdtRtvMtrPsvzdzU_Tpwrm_c-7lHKAp4VLGlFF1iKYYYxlzjtUEnfT9EuOgY36MJoQSKUiaTNHtC-QuM3VUQguDy_rriFxF89q13-oAnRl87ctN5NpoqCAyJUS-2OK-CfgpOipM3cPZfs7Q-8P92_wpXrw-Ps_vFnHFiBpiZZkokjSXwBhkIKiEnChQLDc2I4VJbCElk1ZgA9yqJGdW2pTlwAoKVBI2Qze73NXaNpBn0A6dqfWqc43pNtobp_9vWlfp0n9qQlKeJsF_sfd3_mMN_aCXft214WUdKlFCcLqFzv8e-U3_qSsAlzugcmU1ug5035i6DjjR4zgSkWqmqUjYFyxsdUo</recordid><startdate>20020806</startdate><enddate>20020806</enddate><creator>Polifka, Janine E</creator><creator>Friedman, J.M</creator><general>Can Med Assoc</general><general>CMA Impact, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20020806</creationdate><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><author>Polifka, Janine E ; Friedman, J.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h319t-9b36f57d8e33ece628ed19e93dabc1fa5bf8838b60ae4b95d3b8b73de3f2e2813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Congenital diseases</topic><topic>Drugs</topic><topic>Environmental Exposure</topic><topic>Epilepsy - drug therapy</topic><topic>Female</topic><topic>Genetic Counseling</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Testing</topic><topic>Genetics</topic><topic>Genetics, Medical - trends</topic><topic>Humans</topic><topic>Physiological aspects</topic><topic>Pregnancy</topic><topic>Review</topic><topic>Risk Assessment</topic><topic>Smoking - adverse effects</topic><topic>Teratogens - toxicity</topic><topic>Toxic chemicals</topic><topic>Valproic Acid - adverse effects</topic><topic>Valproic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polifka, Janine E</creatorcontrib><creatorcontrib>Friedman, J.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polifka, Janine E</au><au>Friedman, J.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical genetics: 1. Clinical teratology in the age of genomics</atitle><jtitle>Canadian Medical Association journal</jtitle><addtitle>CMAJ</addtitle><date>2002-08-06</date><risdate>2002</risdate><volume>167</volume><issue>3</issue><spage>265</spage><epage>273</epage><pages>265-273</pages><issn>0008-4409</issn><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><abstract>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</abstract><cop>Canada</cop><pub>Can Med Assoc</pub><pmid>12186175</pmid><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-4409
ispartof Canadian Medical Association journal, 2002-08, Vol.167 (3), p.265-273
issn 0008-4409
0820-3946
1488-2329
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_117475
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Alcohol Drinking - adverse effects
Anticonvulsants - adverse effects
Anticonvulsants - therapeutic use
Congenital diseases
Drugs
Environmental Exposure
Epilepsy - drug therapy
Female
Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing
Genetics
Genetics, Medical - trends
Humans
Physiological aspects
Pregnancy
Review
Risk Assessment
Smoking - adverse effects
Teratogens - toxicity
Toxic chemicals
Valproic Acid - adverse effects
Valproic Acid - therapeutic use
title Medical genetics: 1. Clinical teratology in the age of genomics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20genetics:%201.%20Clinical%20teratology%20in%20the%20age%20of%20genomics&rft.jtitle=Canadian%20Medical%20Association%20journal&rft.au=Polifka,%20Janine%20E&rft.date=2002-08-06&rft.volume=167&rft.issue=3&rft.spage=265&rft.epage=273&rft.pages=265-273&rft.issn=0008-4409&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E153561031%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204966425&rft_id=info:pmid/12186175&rfr_iscdi=true